Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical erythropoietin for second-degree burn wound healing
IRCT20190810044500N23Phase 3Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Apr 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of erythropoietin in burn injury (2 arms), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoint: Wound healing percentage at day 13. Started Apr 2022; status: completed.
02
Drugs
erythropoietin
03
Conditions
burn injury
Beyond the preview
Go deeper on IRCT20190810044500N23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190810044500N23.